Loading…

LYNX EMR - Owned by Oncology Therapeutics Network Corporation - (Class 042) | Sealvo

Home Search: LYNX EMRLYNX EMR #77742275

Updated Sep 19, 2026·17 searches this week

View on USPTO TSDR Find similar marks

LYN

USPTO Trademark Record

ABANDONED

LYNX EMR

SN 77742275·Reg 0·Filed May 21, 2009

Owner Oncology Therapeutics Network Corporation

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

LYNX EMR (Serial No. 77742275), Registration No. 0, is a abandoned US trademark filed on May 21, 2009 by Oncology Therapeutics Network Corporation. This trademark covers Class 042 (Scientific, technology & SaaS services).

Conflict Analysis

Full conflict analysis for LYNX EMR (SN 77742275) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

LYNX EMR (Reg. #0) is an abandoned US trademark that was filed in 2009 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research....

FILED

May 21, 2009

SERIAL

77742275

REG#

0

REGISTERED

Dec 31, 1969

Filing Information

StatusABANDONED

Filing DateMay 21, 2009

Serial Number77742275

Registration No.0

Registration DateDec 31, 1969

Status DateMar 26, 2010

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application Currently

Full Goods & Services

CLASSES

1

OFFICE

USPTO

COUNTRY

US

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Oct 17, 2007

First use in commerce: Oct 17, 2007

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

8 events

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Mar 26, 2010

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

Mar 26, 2010

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

NON-FINAL ACTION WRITTEN

Aug 28, 2009

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 28, 2009

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 28, 2009

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Aug 20, 2009

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 26, 2009

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 25, 2009

NEW APPLICATION ENTERED

Other Marks by Oncology Therapeutics Network Corporation

Additional USPTO filings from the same owner.

LYNX

75240556

Oncology Therapeutics Network Corporation

LYNX PRACTICE MANAGER

78719914

Oncology Therapeutics Network Corporation

LYNX EMR

78828580

Oncology Therapeutics Network Corporation

ONCOLOGY THERAPEUTICS NETWORK

74078105

ONCOLOGY THERAPEUTICS NETWORK CORPORATION

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

LYNX EMR

78828580

Oncology Therapeutics Network Corporation

EMR

74239111

Electric Motor Repair Co., The

LYNX

98250359

Lynx Financial Crime Tech, S.A.

LYNX

90733318

Exela Technologies Inc.